We observed that both IL-33 and IL-18 were highly concentrated in the serum of patients with PCa, suggesting that increased exposure of ILC2s to these cytokines may trigger their proliferation and activity, producing high levels of IL-13. The gene discussed is IL13; the disease is posterior cortical atrophy.